Saunders M - Search Results

1

A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours.

Horsley L, Cummings J, Middleton M, Ward T, Backen A, Clamp A, Dawson M, Farmer H, Fisher N, Halbert G, Halford S, Harris A, Hasan J, Hogg P, Kumaran G, Little R, Parker GJ, Potter P, Saunders M, Roberts C, Shaw D, Smith N, Smythe J, Taylor A, Turner H, Watson Y, Dive C, Jayson GC; Cancer Research UK Drug Development Office Phase I clinical trial. Horsley L, et al. Among authors: saunders m. Cancer Chemother Pharmacol. 2013 Dec;72(6):1343-52. doi: 10.1007/s00280-013-2320-9. Epub 2013 Oct 20. Cancer Chemother Pharmacol. 2013. PMID: 24141375 Clinical Trial.

2

Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer.

O'Byrne KJ, Koukourakis MI, Saunders MP, Salisbury AJ, Isaacs R, Varcoe S, Taylor M, Ganesan TS, Harris AL, Talbot DC. O'Byrne KJ, et al. Among authors: saunders mp. Br J Cancer. 1998 Jun;77(11):1950-6. doi: 10.1038/bjc.1998.323. Br J Cancer. 1998. PMID: 9667673 Free PMC article. Clinical Trial.

3

Does reductive metabolism predict response to tirapazamine (SR 4233) in human non-small-cell lung cancer cell lines?

Chinje EC, Patterson AV, Saunders MP, Lockyer SD, Harris AL, Stratford IJ. Chinje EC, et al. Among authors: saunders mp. Br J Cancer. 1999 Dec;81(7):1127-33. doi: 10.1038/sj.bjc.6690819. Br J Cancer. 1999. PMID: 10584872 Free PMC article.

4

NADPH:cytochrome c (P450) reductase activates tirapazamine (SR4233) to restore hypoxic and oxic cytotoxicity in an aerobic resistant derivative of the A549 lung cancer cell line.

Saunders MP, Patterson AV, Chinje EC, Harris AL, Stratford IJ. Saunders MP, et al. Br J Cancer. 2000 Feb;82(3):651-6. doi: 10.1054/bjoc.1999.0977. Br J Cancer. 2000. PMID: 10682679 Free PMC article.

5

The relative importance of NADPH: cytochrome c (P450) reductase for determining the sensitivity of human tumour cells to the indolequinone EO9 and related analogues lacking functionality at the C-2 and C-3 positions.

Saunders MP, Jaffar M, Patterson AV, Nolan J, Naylor MA, Phillips RM, Harris AL, Stratford IJ. Saunders MP, et al. Biochem Pharmacol. 2000 Apr 15;59(8):993-6. doi: 10.1016/s0006-2952(99)00405-0. Biochem Pharmacol. 2000. PMID: 10692564

6

Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy.

Duff SE, Li C, Jeziorska M, Kumar S, Saunders MP, Sherlock D, O'Dwyer ST, Jayson GC. Duff SE, et al. Among authors: saunders mp. Br J Cancer. 2003 Aug 4;89(3):426-30. doi: 10.1038/sj.bjc.6601145. Br J Cancer. 2003. PMID: 12888807 Free PMC article. Review.

7

Phase I dose-escalation trial of irinotecan with continuous infusion 5-FU first line, in metastatic colorectal cancer.

Saunders MP, Hogg M, Carrington B, Sjursen AM, Allen J, Beech J, Swindell R, Valle JW. Saunders MP, et al. Br J Cancer. 2004 Oct 18;91(8):1447-52. doi: 10.1038/sj.bjc.6602173. Br J Cancer. 2004. PMID: 15452550 Free PMC article. Clinical Trial.

8

Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volume.

Jayson GC, Parker GJ, Mullamitha S, Valle JW, Saunders M, Broughton L, Lawrance J, Carrington B, Roberts C, Issa B, Buckley DL, Cheung S, Davies K, Watson Y, Zinkewich-Péotti K, Rolfe L, Jackson A. Jayson GC, et al. Among authors: saunders m. J Clin Oncol. 2005 Feb 10;23(5):973-81. doi: 10.1200/JCO.2005.01.032. Epub 2004 Oct 4. J Clin Oncol. 2005. PMID: 15466784 Clinical Trial.

9

Pre-operative plasma levels of vascular endothelial growth factor A, C and D in patients with colorectal cancer.

Duff SE, Saunders M, McCredie V, Kumar S, O'Dwyer ST, Jayson GC. Duff SE, et al. Among authors: saunders m. Clin Oncol (R Coll Radiol). 2005 Aug;17(5):367-71. doi: 10.1016/j.clon.2005.03.002. Clin Oncol (R Coll Radiol). 2005. PMID: 16097569

10

Management of advanced colorectal cancer: state of the art.

Saunders M, Iveson T. Saunders M, et al. Br J Cancer. 2006 Jul 17;95(2):131-8. doi: 10.1038/sj.bjc.6603233. Br J Cancer. 2006. PMID: 16835584 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,735 results

Search Page

Filters